SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-005930
Filing Date
2019-03-04
Accepted
2019-03-04 08:00:34
Documents
6
Period of Report
2019-02-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K phas-8k_20190227.htm 8-K 43267
2 EX-10.1 phas-ex101_22.htm EX-10.1 18641
3 EX-99.1 phas-ex991_6.htm EX-99.1 8924
4 EX-99.2 phas-ex992_7.htm EX-99.2 10542
5 GRAPHIC gwib53g0rwpq000001.jpg GRAPHIC 2392
6 GRAPHIC gaa0nu0suxid000001.jpg GRAPHIC 2392
  Complete submission text file 0001564590-19-005930.txt   89760
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 19651907
SIC: 2834 Pharmaceutical Preparations